Table 3.
Characteristic | Univariate analysis | Multivariate analysis | |
---|---|---|---|
P | Hazard ratio (95% CI) | P | |
Age (y) | <0.001 | ||
<51 | Reference | ||
51–58 | 1.216 (0.969–1.524) | 0.09 | |
>58 | 1.701 (1.379–2.097) | <0.001 | |
Race | 0.106 | ||
White | |||
Black | |||
Other* | |||
Year at diagnosis | 0.490 | ||
2004–2009 | |||
2010–2015 | |||
Grade** | <0.001 | ||
Low | Reference | ||
High | 2.591 (1.909–3.515) | <0.001 | |
Stage | <0.001 | ||
I | Reference | ||
II | 2.387 (1.757–3.243) | <0.001 | |
III | 3.661 (2.716–4.934) | <0.001 | |
IV | 4.795 (3.818–6.022) | <0.001 | |
Tumor size (mm) | <0.001 | ||
<70 | Reference | ||
70–140 | 1.477 (1.155–1.890) | 0.002 | |
>140 | 2.161 (1.659–2.812) | <0.001 | |
Lymphadenectomy | 0.221 | ||
Yes | |||
No | |||
Surgery type | <0.001 | ||
Hysterectomy** | Reference | ||
Pelvic exenteration | 0.814 (0.443–1.495) | 0.507 | |
No surgery | 2.312 (1.603–3.335) | <0.001 | |
Radiotherapy | 0.058 | ||
Yes | |||
No | |||
Chemotherapy | <0.001 | ||
Yes | Reference | ||
No | 1.171 (0.965–1.423) | 0.109 |
CI – confidence interval.
American Indian/Alaskan Native, Asian/Pacific Islander;
Low: Grade I (well differentiated) and Grade II (moderately differentiated); High: Grade III (poorly differentiated) and Grade IV (undifferentiated anaplastic);
Total/simple/pan/radical hysterectomy with or without removal of adnexa.